Publicacións en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (26)

2023

  1. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

    Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33

  2. Cardiogenic shock code 2023. Expert document for a multidisciplinary organization that allows quality care

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 261-269

  3. Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

    Antibiotics, Vol. 11, Núm. 9

  2. Risk factors for mortality in patients with COVID-19 needing extracorporeal respiratory support

    European Respiratory Journal

2021

  1. Correction to: Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety (Drugs in R&D, (2021), 21, 1, (39-64), 10.1007/s40268-020-00329-w)

    Drugs in R and D

  2. Epidemiology and prognosis of patients with a history of cancer admitted to intensive care. A multicenter observational study

    Medicina Intensiva, Vol. 45, Núm. 6, pp. 332-346

  3. Organization of attention to infectious pathology in critical care units in Spain

    Medicina Intensiva, Vol. 45, Núm. 8, pp. e25-e28

  4. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

  5. Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety

    Drugs in R and D, Vol. 21, Núm. 1, pp. 39-64

2020

  1. Recommendations for specialized nutritional-metabolic management of the critical patient: introduction, methodology and list of recommendations. Metabolism and Nutrition Working Group of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC)

    Medicina Intensiva, Vol. 44, pp. 1-14

  2. Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)

    Medicina Intensiva, Vol. 44, Núm. 6, pp. 371-388

  3. Update of the treatment of nosocomial pneumonia in the ICU

    Critical Care, Vol. 24, Núm. 1

2019

  1. Practical document on the management of hyponatremia in critically ill patients

    Medicina Intensiva, Vol. 43, Núm. 5, pp. 302-316

  2. Preliminary results of the ADENI-ICU trial: Analysis of decisions of refuse admission in intensive care units as a limitation of life support treatments; multi-center, prospective, observational study

    Medicina Intensiva, Vol. 43, Núm. 5, pp. 317-319

2018

  1. Application of BioFire FilmArray Blood Culture Identification panel for rapid identification of the causative agents of ventilator-associated pneumonia

    Clinical Microbiology and Infection, Vol. 24, Núm. 11, pp. 1213.e1-1213.e4

  2. Improved empirical antibiotic treatment of sepsis after an educational intervention: The ABISS-Edusepsis study

    Critical Care, Vol. 22, Núm. 1

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1

2015

  1. Safety and efficacy of colistin versus meropenem in the empirical treatment of ventilator-associated pneumonia as part of a macro-project funded by the Seventh Framework Program of the European Commission studying off-patent antibiotics: Study protocol for a randomized controlled trial

    Trials, Vol. 16, Núm. 1

2014

  1. Infections, antibiotic treatment and mortality in patients admitted to ICUs in countries considered to have high levels of antibiotic resistance compared to those with low levels

    BMC Infectious Diseases, Vol. 14, Núm. 1